2BBBullish & Bearish
MannKind Corporation (MNKD) trades on NASDAQ. It operates in the Health Care sector, Biotechnology industry. Its current 2BB score is 62 out of 100.
MannKind Corporation is a biopharmaceutical company focusing on the discovery, development, and commercialization of therapeutic products for diseases such as diabetes and pulmonary arterial hypertension. Based in Danbury, Connecticut, the company was founded in February 1991. MannKind Corporation was named after its founder, Alfred E. Mann.
MannKind Corporation’s current 2BB score is 62 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 80 | Very High |
| Momentum | 60 | Stable |
| Financial strength | 38 | Weak |
| Quality | 97 | Very Strong |
| Risk | 52 | Moderate |
| CEO | Michael Castagna |
| Headquarters | Danbury, Connecticut, United States |
| Founded | Feb 1991 |
| Employees | 592 |
| 52-week range | $2.23 – $6.51 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-24 | — | -0.0128 | — | $136.34M |
| 2026-11-03 | — | -0.0561 | — | $112.45M |
| 2026-08-05 | — | -0.0026 | — | $111.09M |
| 2026-05-06 | -0.05 | -0.0015 | $90.17M | $108.69M |